Redcare Pharmacy stock at EUR 71.93, down 0.79% premarket
Published on 11/06/2026 at 08:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat matters for investors
- Redcare Pharmacy says it delivers more than 100,000 packages daily across Europe.
- The company lists investor conferences in London on November 18 and Paris on November 19.
- Redcare's October 29 update said prescription operations drove 18% revenue growth in the third quarter, while adjusted EBITDA margin improved to 3.4%.
Redcare Pharmacy stock traded at EUR 71.93 on Lang & Schwarz at 08:19 CET on Friday, November 6, 2026, 0.79% below the Xetra close of Thursday, November 5, at EUR 72.50.
Redcare Pharmacy's investor-relations site describes the company as Europe's leading online pharmacy. It says the business delivers more than 100,000 packages a day and serves customers across Europe.
Prescription growth remains central
Redcare's latest quarterly update said revenue increased 18% in the third quarter of 2026, with the prescription business driving the expansion. The adjusted EBITDA margin improved to 3.4%, an increase of 1.0 percentage point, according to the October 29 release.
The company has kept its 2026 targets after the strong quarter. For investors, prescription volume and the ability to convert that growth into sustainable profitability remain the main operating indicators.
Redcare Pharmacy will appear at the Jefferies Global Healthcare Conference in London on November 18 and at the Bank of America EMEA Consumer Conference in Paris on November 19.
The DAX provides the relevant benchmark for the German market backdrop.
For more, see more news and analyses on Redcare Pharmacy stock.
